Episode Details

New hope for severe alopecia areata: Upadacitinib, known as Rinvoq, shows remarkable results in restoring scalp hair—with some patients regrowing up to 80% coverage and even achieving full scalp regrowth. Originally used for rheumatoid arthritis, this JAK inhibitor targets the immune system’s attack on hair follicles. In large trials involving nearly 1,400 adults and teens with extensive hair loss, significant improvements were seen not just on the scalp but also in eyebrows and eyelashes. Already approved in Europe, it’s under FDA review in the U.S., offering a much-needed new option in an expanding arsenal of treatments for this autoimmune condition.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/c24a0d4c5b751728